Cargando…
Blood Pressure Lowering With Nilvadipine in Patients With Mild‐to‐Moderate Alzheimer Disease Does Not Increase the Prevalence of Orthostatic Hypotension
BACKGROUND: Hypertension is common among patients with Alzheimer disease. Because this group has been excluded from hypertension trials, evidence regarding safety of treatment is lacking. This secondary analysis of a randomized controlled trial assessed whether antihypertensive treatment increases t...
Autores principales: | de Heus, Rianne A. A., Donders, Rogier, Santoso, Angelina M. M., Olde Rikkert, Marcel G. M., Lawlor, Brian A., Claassen, Jurgen A. H. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585342/ https://www.ncbi.nlm.nih.gov/pubmed/31088188 http://dx.doi.org/10.1161/JAHA.119.011938 |
Ejemplares similares
-
Orthostatic Blood Pressure Recovery Is Associated With the Rate of Cognitive Decline and Mortality in Clinical Alzheimer’s Disease
por: de Heus, Rianne A A, et al.
Publicado: (2020) -
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
por: Lawlor, Brian, et al.
Publicado: (2018) -
Diagnostic accuracy of office blood pressure compared to home blood
pressure in patients with mild cognitive impairment and dementia
por: de Heus, Rianne AA, et al.
Publicado: (2019) -
NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease
por: Lawlor, Brian, et al.
Publicado: (2014) -
Head Turning-Induced Hypotension in Elderly People
por: Schoon, Yvonne, et al.
Publicado: (2013)